- Home
- STXS vs INFU Comparison
STXS vs INFU Comparison
Compare STXS & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STXS
- INFU
- Stock Information
- Founded
- STXS 1990
- INFU 2005
- Country
- STXS United States
- INFU United States
- Employees
- STXS N/A
- INFU N/A
- Industry
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- INFU Medical/Dental Instruments
- Sector
- STXS Health Care
- INFU Health Care
- Exchange
- STXS Nasdaq
- INFU Nasdaq
- Market Cap
- STXS N/A
- INFU 189.2M
- IPO Year
- STXS 2004
- INFU N/A
- Fundamental
- Price
- STXS $2.19
- INFU $8.12
- Analyst Decision
- STXS Strong Buy
- INFU
- Analyst Count
- STXS 2
- INFU 0
- Target Price
- STXS $4.50
- INFU N/A
- AVG Volume (30 Days)
- STXS 337.8K
- INFU 68.4K
- Earning Date
- STXS 03-03-2025
- INFU 03-13-2025
- Dividend Yield
- STXS N/A
- INFU N/A
- EPS Growth
- STXS N/A
- INFU 60.96
- EPS
- STXS N/A
- INFU 0.07
- Revenue
- STXS $25,143,000.00
- INFU $132,783,999.00
- Revenue This Year
- STXS $3.73
- INFU $10.23
- Revenue Next Year
- STXS $54.27
- INFU $8.80
- P/E Ratio
- STXS N/A
- INFU $115.57
- Revenue Growth
- STXS N/A
- INFU 8.17
- 52 Week Low
- STXS $1.66
- INFU $5.74
- 52 Week High
- STXS $3.29
- INFU $9.97
- Technical
- Relative Strength Index (RSI)
- STXS 48.66
- INFU 48.91
- Support Level
- STXS $2.21
- INFU $7.86
- Resistance Level
- STXS $2.22
- INFU $8.25
- Average True Range (ATR)
- STXS 0.13
- INFU 0.28
- MACD
- STXS -0.01
- INFU 0.02
- Stochastic Oscillator
- STXS 23.19
- INFU 70.00
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The first platform is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair.